About Invistics
Invistics is a company based in Norcross (United States) founded in 1999 was acquired by Wolters Kluwer in June 2023.. Invistics has raised $7.5 million across 3 funding rounds from investors including Wolters Kluwer, Atlanta Technology Angels and Intersouth Partners. Invistics offers products and services including Sentri7 Drug Diversion, UpToDate, and CCH Axcess. Invistics operates in a competitive market with competitors including Syncron, DecisionPoint, Generix Group, HighJump and Logiwa, among others.
- Headquarter Norcross, United States
-
Sectors
Technology
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Invistics Corporation
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$7.5 M (USD)
in 3 rounds
-
Latest Funding Round
$5 M (USD), Series B
Jan 28, 2005
-
Investors
Wolters Kluwer
& 4 more
-
Employee Count
Employee Count
-
Acquired by
Wolters Kluwer
(Jun 07, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Invistics
Invistics offers a comprehensive portfolio of products and services, including Sentri7 Drug Diversion, UpToDate, and CCH Axcess. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Software for detecting drug diversion and ensuring compliance in healthcare
Platform providing trusted medical information for clinical decision-making
Cloud-based tools for tax preparation and workflow management
Unlock access to complete
Unlock access to complete
Funding Insights of Invistics
Invistics has successfully raised a total of $7.5M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $5 million completed in January 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $5.0M
-
First Round
First Round
(28 Aug 2003)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2005 | Amount | Series B - Invistics | Valuation |
investors |
|
| Mar, 2004 | Amount | Grant - Invistics | Valuation |
investors |
|
| Aug, 2003 | Amount | Series A - Invistics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Invistics
Invistics has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Wolters Kluwer, Atlanta Technology Angels and Intersouth Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage life sciences and tech focused VC firm funding companies in the US
|
Founded Year | Domain | Location | |
|
Angel investments are provided across Atlanta and Georgia.
|
Founded Year | Domain | Location | |
|
Private equity capital is invested in small and mid-sized businesses.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Invistics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Invistics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Invistics Comparisons
Competitors of Invistics
Invistics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Syncron, DecisionPoint, Generix Group, HighJump and Logiwa, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of cloud-based inventory optimization software
|
|
| domain | founded_year | HQ Location |
Provider of a field service and warehouse management solution
|
|
| domain | founded_year | HQ Location |
Supply chain management and collaboration solutions are provided globally.
|
|
| domain | founded_year | HQ Location |
Cloud-based warehouse management software is supplied for logistics operations.
|
|
| domain | founded_year | HQ Location |
Cloud-based warehouse management systems are provided for e-commerce fulfillment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Invistics
Frequently Asked Questions about Invistics
When was Invistics founded?
Invistics was founded in 1999 and raised its 1st funding round 4 years after it was founded.
Where is Invistics located?
Invistics is headquartered in Norcross, United States. It is registered at Norcross, Georgia, United States.
Is Invistics a funded company?
Invistics is a funded company, having raised a total of $7.5M across 3 funding rounds to date. The company's 1st funding round was a Series A of $2.5M, raised on Aug 28, 2003.
What does Invistics do?
Invistics was founded in 1999 in Norcross, United States, focusing on the supply chain and manufacturing sectors. Consulting services and software solutions are delivered to support supplier collaboration and optimize inventory levels through analytics and simulation. Manufacturing batch and lot optimization is facilitated, along with quote lead time calculations grounded in Six Sigma and lean principles. Clients served include Bristol-Myers Squibb, DuPont, Coca-Cola, and Siemens.
Who are the top competitors of Invistics?
Invistics's top competitors include Generix Group, Syncron and DecisionPoint.
What products or services does Invistics offer?
Invistics offers Sentri7 Drug Diversion, UpToDate, and CCH Axcess.
Who are Invistics's investors?
Invistics has 5 investors. Key investors include Wolters Kluwer, Atlanta Technology Angels, Intersouth Partners, H.I.G. Capital, and National Science Foundation.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.